APP and Alzheimer disease: A recent study performed in a cell model of AD showed that Aβ production increases in a resveratrol dose- and time-dependent manner via stabilization of amyloid precursor protein (APP), and AMPK-mediated inhibition of trypsin-like proteasome activity [152].